bpc-157 subcutaneous or intramuscular BPC-157: The Body Protection Compound bpc-157 intramuscular or subcutaneous injection

When I went after BPC-157, I was talking about a specific molecule, sold through gray market suppliers and unregulated compounding pharmacies, that people are injecting subcutaneously into their muscle tissue, into their joints based on animal data from a single research group in Zagreb

The shortage of geriatricians and other relevant specialists has been attributed to a combination of factors, including a smaller percentage of workingaged adults

Very common with any injectable

Oral NR (strongest human RCT base) Multiple RCTs (Martens 2018, Conze 2019, Dollerup 2018, Brakedal 2022) consistently raised blood NAD+ with favorable tolerability at doses up to 1,000 mg/day